John Gallagher, MD
Plastic Surgery within the Head & Neck · Langhorne, PANPI 1508846957
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.
Across 171 payments — averaging $21.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$724
- GSK$616
- Optinose US, Inc.$472
- Inspire Medical Systems, Inc.$337
- Sanofi$321
- Stryker$214
- plus $963 from 22 others
What the payments were for
- Food & beverage$3,647100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 33 | $724 |
| GSK | 26 | $616 |
| Optinose US, Inc. | 30 | $472 |
| Inspire Medical Systems, Inc. | 9 | $337 |
| Sanofi | 16 | $321 |
| Stryker | 8 | $214 |
| Alk-abello, Inc | 8 | $125 |
| Acclarent, Inc | 6 | $113 |
| Aerin Medical Inc. | 5 | $87 |
| Intersect ENT, Inc. | 3 | $68 |
| Smith+Nephew | 2 | $67 |
| Arbor Pharmaceuticals, Inc. | 4 | $61 |
| Arrinex, Inc. | 1 | $50 |
| Merck | 3 | $50 |
| Abiomed | 1 | $37 |
| Fujifilm Healthcare Americas Corporation | 1 | $35 |
| Cochlear Americas | 1 | $30 |
| Olympus America Inc. | 2 | $30 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Urovant Sciences Inc | 2 | $29 |
| Merz North America, Inc. | 1 | $25 |
| Davol Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Fujifilm New Development USA, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $12 |
| Cook Medical LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,647 in reported general payments places this provider in the 80th percentile of 20 plastic surgery within the head & neck providers in Pennsylvania.
See all plastic surgery within the head & neck providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $47,798 |
| XhanceFluticasone Propionate | 20 | $14,055 |
| Ipratropium Bromide | 214 | $10,360 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 64 | $7,305 |
| Mometasone Furoate | 42 | $5,052 |
| Cevimeline Hcl | 21 | $3,787 |
| Fluticasone Propionate | 166 | $3,753 |
| Cefdinir | 155 | $3,631 |
| Azelastine Hcl | 99 | $3,229 |
| Levothyroxine Sodium | 143 | $2,946 |
| SynthroidLevothyroxine Sodium | 32 | $2,833 |
| Montelukast Sodium | 176 | $2,293 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 177 | $1,955 |
| Betamethasone Dipropionate | 35 | $1,550 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 24 | $1,471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $472 | $14,05520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 20 plastic surgery within the head & neck providers in Pennsylvania.
Other plastic surgery within the head & neck in Langhorne
- Benjamin ChackLanghorne$2K
- Sumeet MathurJohnstown$17K
- Joseph SmithExton$8K
- Christopher RassekhPhiladelphia$5K
- Alison YuPhiladelphia$3K
- Aarti AgarwalPhiladelphia$3K
- Neel SangalLancaster$3K
- Gunnar BergqvistErie$2K
- Florence OthienoLancaster$1K
- Lisa AyersLewisburg$593
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.